Stay updated on Mepolizumab in Urban Children Asthma Trial
Sign up to get notified when there's something new on the Mepolizumab in Urban Children Asthma Trial page.

Latest updates to the Mepolizumab in Urban Children Asthma Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no visible changes to the study details or page content are indicated.SummaryDifference0.0%

- Check40 days agoChange DetectedMinor revision update from v3.4.0 to v3.4.1; no substantive changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded a 'Show glossary' control and updated the QC field label to 'Last Update Submitted that Met QC Criteria' with the revision version updated to v3.4.0. Updated labeling for No FEAR Act data to 'No FEAR Act Data' and adjusted capitalization related to the revision reference (from v3.3.4 to v3.4.0).SummaryDifference0.2%

- Check62 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedA new Locations section lists trial sites by state: Colorado, District of Columbia, Illinois, Massachusetts, Michigan, Missouri, New York, Ohio, and Texas. Per-state location subsections were removed and the page revision updated to v3.3.3.SummaryDifference0.9%

Stay in the know with updates to Mepolizumab in Urban Children Asthma Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Urban Children Asthma Trial page.